Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Temam

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 5, 2014
Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?A Levy, P Blanchard, S Temam, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 13, 2016
[Oral cavity cancers among young people: Clinical results and prognostic analysis]P Blanchard, C El Khoury, S Temam, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.
British Journal of Cancer|August 11, 2011
Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neckJ M Del Campo, R Hitt, P Sebastian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinomaS Temam, J Spicer, F Farzaneh, et al.
Revue Des Maladies Respiratoires|March 22, 2015
[Genetic and environmental factors of asthma and allergy: Results of the EGEA study]E Bouzigon, R Nadif, N Le Moual, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 5, 2014
Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?A Levy, P Blanchard, S Temam, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 13, 2016
[Oral cavity cancers among young people: Clinical results and prognostic analysis]P Blanchard, C El Khoury, S Temam, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 1, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part 2: Remote extension assessment and exploration for secondary synchronous locations outside of the upper aerodigestive tract. 2012 SFORL guidelinesE de Monès, C Bertolus, P Y Salaun, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|January 26, 2013
Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx). Part I: Locoregional extension assessment: 2012 SFORL guidelinesS Vergez, S Morinière, F Dubrulle, et al.
British Journal of Cancer|August 11, 2011
Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neckJ M Del Campo, R Hitt, P Sebastian, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable head and neck squamous cell carcinomaS Temam, J Spicer, F Farzaneh, et al.
Revue Des Maladies Respiratoires|March 22, 2015
[Genetic and environmental factors of asthma and allergy: Results of the EGEA study]E Bouzigon, R Nadif, N Le Moual, et al.
Pageof 4